|
|
Volume
7: No. 3, May 2010
ORIGINAL RESEARCH
Prevalence, Awareness, Treatment, and Control of High LDL Cholesterol in New York City, 2004
| ATP III Risk Group |
% of NYC Adults |
| Low |
| Normal LDL cholesterol |
59.5 |
| High LDL cholesterol/aware |
4.3 |
| High LDL cholesterol/unaware |
1.0 |
| Moderate |
| Normal LDL cholesterol |
7.2 |
| High LDL cholesterol/aware |
2.8 |
| High LDL cholesterol/unaware |
0.5 |
| Moderately high |
| Normal LDL cholesterol |
2.6 |
| High LDL cholesterol/aware |
2.5 |
| High LDL cholesterol/unaware |
1.5 |
| High |
| Normal LDL cholesterol |
2.8 |
| High LDL cholesterol/aware |
10.1 |
| High LDL cholesterol/unaware |
5.0 |
Figure. Age-standardized prevalence of high LDL cholesterol among NYC adults by ATP-III risk category (5,14), New York City Health and Nutrition Examination Survey, 2004. High LDL cholesterol defined as currently taking cholesterol-lowering medications or having LDL cholesterol levels at or greater than the ATP-III risk-specific thresholds recommended for initiation of drug therapy: ≥100 mg/dL for the high-risk group, ≥130 mg/dL for the moderately high-risk group,
≥160 mg/dL for the moderate-risk group, and ≥190 mg/dL for the low-risk group.
Return to article
|
|
![](/navimages/spacer.gif"){kind=spacer}
